Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daily observation of inhalation of tobramycin inhalation powder
NL-OMON43918Recruiting
- Sponsor
- Erasmus MC
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tobramycin in cystic fibrosis (CF), sponsored by Erasmus MC. Primary endpoint: Percentage of patients by inhalation maneuver category during TIP. Started Jun 2015; status: recruiting.
02
Drugs
tobramycin
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NL-OMON43918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43918.